Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example von Aroda, Vanita R., Saugstrup, Trine, Buse, John B., Donsmark, Morten, Zacho, Jeppe, Davies, Melanie J.

Volltext

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial von Pratley, Richard, Amod, Aslam, Hoff, Søren Tetens, Kadowaki, Takashi, Lingvay, Ildiko, Nauck, Michael, Pedersen, Karen Boje, Saugstrup, Trine, Meier, Juris J

Volltext

Safe Application of a Restrictive Transfusion Protocol in Moderate-Risk Patients Undergoing Cardiac Operations von Song, Howard K., MD, PhD, von Heymann, Christian, MD, Jespersen, Christian M., MD, Karkouti, Keyvan, MD, Korte, Wolfgang, MD, Levy, Jerrold H., MD, Ranucci, Marco, MD, Saugstrup, Trine, MS, Sellke, Frank W., MD

Volltext

55-OR: Oral Semaglutide vs. Liraglutide and Placebo in T2D: PIONEER 4 von PRATLEY, RICHARD E., AMOD, ASLAM, HOFF, SOREN T., KADOWAKI, TAKASHI, LINGVAY, ILDIKO, NAUCK, MICHAEL A., PEDERSEN, KAREN BOJE, SAUGSTRUP, TRINE, MEIER, JURIS J.

Volltext

Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m2) – a Post-Hoc Sub-Analysis of the guardian™ Trials von Recht, Michael, Lentz, Steven R., Zupancic-Šalek, Silva, Matytsina, Irina, Landorph, Andrea, Saugstrup, Trine

Volltext

The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots von Jiménez-Yuste, Víctor, Lejniece, Sandra, Klamroth, Robert, Saugstrup, Trine, Moss, Judi

Volltext